跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IBUPROFEN CAPLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IBUPROFEN CAPLETS
Authorized
STANDARD
IBUPROFEN CAPLETS
vita health products inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d8eddca6b152abfe
Company
vita health products inc
Type
Standard
Approval Details
Approval Id
d8eddca6b152abfe
Drug Approval Canada Name
IBUPROFEN CAPLETS
Product Name
IBUPROFEN CAPLETS
Status
Marketed
Status Date
2017-01-26
Original Market Date
2017-01-26
Din
02368080
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.92
Atc Original
M01AE01 IBUPROFEN
Atc Name
m 01 ae 01
Aig Number
0108883004
Company Name
vita health products inc
Company Address
150 Beghin Avenue, Winnipeg, Manitoba, Canada, R2J 3W2
Active Ingredients
IBUPROFEN
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d8eddca6b152abfe
Type
Standard
Back to Health Canada Approvals